Surprises in the Physiopathology of Critical Ischemia

Luminal thrombotic occlusions associated with non-significant atherosclerosis are commonly observed in patients with critical lower limb ischemia, which suggests the possibility of thromboembolic disease as a great contributor to ischemia. This was particularly verifiable in infrapopliteal vessels, thus showing a possible mechanism of progression from peripheral vascular disease to critical ischemia, as well as a possible role for antithrombotic agents.

¿Es durable el TAVI a más de 5 años?Arteries from 95 patients (121 amputations) were studied; 75 of these patients had suffered amputations due to critical ischemia, while the remaining had amputations for other reasons. The pathological characteristics were recorded separately for the femoral artery, the popliteal artery, and infrapopliteal arteries.

 

In the 239 arteries from patients with critical ischemia, atherosclerotic plaques were more frequently found in the femoropopliteal area compared with the infrapopliteal area (67.6% vs. 38.5%; odds ratio [OR]: 5.47; p = 0.003). Among these 239 arteries, 69% presented ≥70% stenosis as a consequence of pathological intimal thickening, fibroatheroma, fibrocalcific lesions, or restenosis. Others were associated with luminal thrombi (23.6%) or thrombi without significant atherosclerotic lesions.


Read also: Differences in Stroke between TAVR and SAVR in Intermediate Risk Patients.


The presence of chronic luminal thrombi was more frequent in arteries with non-significant atherosclerosis (OR: 16.7; p = 0.002), which was more common in infrapopliteal arteries than in femoropopliteal arteries (p = 0.0041). However, acute thrombotic occlusion was less frequent in arteries with larger diameter.

 

Conclusion

Thrombotic luminal occlusion is frequently associated with non-significant atherosclerosis and it is usually observed in patients with critical ischemia who required amputation. Thrombosis may be a mechanism of progression from intermittent claudication to critical ischemia, and a possible role for antithrombotic agents is suggested.

 

Original title: Pathology of Peripheral Artery Disease in Critical Limb Ischemia.

Reference: Navneet Narula et al. J Am Coll Cardiol 2018. Online before print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...